New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Quantum Biopharma Ltd. (QNTM) vs Tvardi Therapeutics, Inc. (TVRD)

Quantum Biopharma Ltd. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Quantum Biopharma Ltd. and Tvardi Therapeutics, Inc. are of similar size ($12.6M and $12.6M). Tvardi Therapeutics, Inc. has the higher net margin (−459.3% vs −16,880.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Tvardi Therapeutics, Inc. leads on 11 and Quantum Biopharma Ltd. on 4.

Valuation

Metric QNTM TVRD Biotechnology median
P/E n/m n/m 8.49
P/S 44.07 1.65 8.56
P/B 1.05 0.81 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA 0.21 0.35 0.69
EV/Sales (9.50) (1.29) 8.00
Earnings yield (335.89%) (271.11%) (35.81%)
Free cash flow yield (104.08%) (216.75%) (25.41%)

Profitability

Metric QNTM TVRD Biotechnology median
Gross margin (1,068.29%) 146.85% 70.18%
Operating margin (9,699.83%) (36.92%) 0.00%
Net margin (16,880.72%) (459.31%) 0.00%
Free cash flow margin (6,089.39%) 58.90% 0.00%
Return on equity (233.09%) (123.08%) (51.58%)
Return on assets (127.92%) (85.24%) (45.91%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric QNTM TVRD Biotechnology median
Revenue growth (TTM) — (55.30%) 7.20%
EPS growth (last fiscal year) 37.50% 71.45% 29.04%
Revenue growth, 5-year CAGR — (18.53%) 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric QNTM TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.72 2.86 4.79
Net debt to EBITDA 0.31 1.15 1.01

Dividend

Metric QNTM TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric QNTM TVRD Biotechnology median
Market cap 12.62m 12.64m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack